🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12496+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12496 recruiting trials

Phase 1RecruitingNCT06021626

A Study of CRD3874-SI in People With Solid Tumors

👨‍⚕️ Ciara Kelly, MBBCH BAO, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2023View details ↗
Enrolling by InvitationNCT05908669

Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

🏥 University of Aarhus📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05328024

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma

🏥 Institut de cancérologie Strasbourg Europe📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05955014

Data Collection Protocol for Patients With Von Hippel Lindau Disease

👨‍⚕️ Eric Jonasch, MD, ejonasch@mdanderson.org📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT06422650

Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia

👨‍⚕️ Farzana Siddiqua, MBBS, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh📍 1 site📅 Started Aug 2023View details ↗
NARecruitingNCT06055036

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

👨‍⚕️ Joshua Joseph, MD, Ohio State University📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT06603402

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

👨‍⚕️ zhenyu ding, MD, West China Hospital, Sichuan University, China📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT05974449

Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients

👨‍⚕️ Jue Wang, MD, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT06526741

ASF Alport Patient Registry

👨‍⚕️ Benjamin A Weinstock, PhD, Alport Syndrome Foundation📍 1 site📅 Started Aug 2023View details ↗
EARLY_Phase 1Enrolling by InvitationNCT06565572

Antisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1

🏥 University of Colorado, Denver📍 1 site📅 Started Aug 2023View details ↗
NARecruitingNCT05811936

The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

👨‍⚕️ Katherine R Sterba, PhD, MPH, Medical University of South Carolina📍 1 site📅 Started Aug 2023View details ↗
NARecruitingNCT05715086

UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones

👨‍⚕️ Thomas Chi, MD, University of California, San Francisco📍 1 site📅 Started Aug 2023View details ↗
Phase 1, PHASE2RecruitingNCT05878860

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

🏥 Atsena Therapeutics Inc.📍 4 sites📅 Started Aug 2023View details ↗
Phase 1, PHASE2RecruitingNCT06975618

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)

🏥 Haihe Biopharma Co., Ltd.📍 4 sites📅 Started Aug 2023View details ↗
RecruitingNCT05697159

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

👨‍⚕️ Neil Basu, MD, PhD, University of Glasgow📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT06039631

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

🏥 Fudan University📍 1 site📅 Started Aug 2023View details ↗
Phase 2RecruitingNCT05597345

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

👨‍⚕️ Jodi Lipof, University of Rochester📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT06355934

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

🏥 AstraZeneca📍 26 sites📅 Started Aug 2023View details ↗
Phase 1, PHASE2RecruitingNCT05874414

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

👨‍⚕️ Peter Lichten, M.D., Genfit📍 11 sites📅 Started Aug 2023View details ↗
RecruitingNCT06006832

A Prospective Cohort Study of Myasthenia Gravis in China

👨‍⚕️ Yuzhou Guan, Peking Union Medical College Hospital📍 1 site📅 Started Aug 2023View details ↗
← PreviousPage 383 of 625Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →